DELUCCIA ROBERT J 4
4 · Acurx Pharmaceuticals, Inc. · Filed Jul 6, 2021
Insider Transaction Report
Form 4
DELUCCIA ROBERT J
Director10% Owner
Transactions
- Award
Stock Option
2021-07-01+500,000→ 500,000 totalExercise: $6.18Exp: 2031-06-30→ Common Stock (500,000 underlying) - Award
Stock Option
2021-06-29+350,000→ 350,000 totalExercise: $6.26Exp: 2031-06-28→ Common Stock (350,000 underlying)
Footnotes (2)
- [F1]On June 29, 2021 (the "June Grant Date"), the Reporting Person was granted stock options to purchase 350,000 shares of the Issuer's common stock. 40% of the stock options granted became vested and exercisable on the June Grant Date and 60% of the stock options shall become vested and exercisable as of each monthly anniversary from the June Grant Date, such that all stock options shall be fully vested and exercisable by June 29, 2024. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person.
- [F2]On July 1, 2021 (the "Employment Agreement Grant Date"), the Reporting Person was granted stock options to purchase 500,000 shares of the Issuer's common stock in connection with the Reporting Person's service as the Issuer's Executive Chairman pursuant to the Reporting Person's employment agreement. 25% of the stock options granted became vested and exercisable on the Employment Agreement Grant Date and 75% of the stock options shall become vested and exercisable as of each monthly anniversary from the Employment Agreement Grant Date, such that all stock options shall be fully vested and exercisable by July 1, 2024.